AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 to inhibit the migration of H1299 cells with high endogenous IGF2BP1 expression.
Molecular Weight:
469.53
Purity:
>99.0%
CAS Number:
[2775241-92-2]
Formula:
C28H27N3O4
Target:
Insulin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted